Literature DB >> 30522064

Simultaneous analysis of acetylcarnitine, proline, hydroxyproline, citrulline, and arginine as potential plasma biomarkers to evaluate NSAIDs-induced gastric injury by liquid chromatography-tandem mass spectrometry.

Soyoung Shin1, Hyeon Myeong Jeong2, Seung Eun Chung2, Tae Hwan Kim3, Subindra Kazi Thapa1, Da Young Lee2, Chang Ho Song2, Jun Young Lim2, Sang-Min Cho4, Kyu-Yeol Nam4, Won-Ho Kang4, Youn-Woong Choi4, Beom Soo Shin5.   

Abstract

Although major adverse effects associated with nonsteroidal anti-inflammatory drugs (NSAIDs) are gastric injury, assessment of NSAIDs-induced gastrointestinal adverse effects is mostly dependent on endoscopy due to the lack of plasma biomarkers. Several amino acids associated with collagenase activity and gastric mucosal mass have been suggested as plasma biomarker candidates for gastric injury. Therefore, this study aimed to develop a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the plasma biomarker candidates, i.e., acetylcarnitine, proline, hydroxyproline, citrulline, and arginine and evaluate their potential as a biomarker for NSAIDs-induced gastric injury. The method utilized simple protein precipitation with methanol and D4-citrulline as an internal standard (IS). The assay resulted in the lower limit of quantification (LLOQ) of 0.1 μg/mL for acetylcarnitine and 1 μg/mL for proline, hydroxyproline, citrulline, and arginine in the surrogate blank plasma. The intra- and inter-day accuracy ranged 82.5-111.2% for acetylcarnitine, 95.4-103.3% for proline, 98.9-106.4% for hydroxyproline, 99.5-103.5% for citrulline, and 87.4-105.3% for arginine. The precision was within 6.17%, 3.63%, 6.20%, 6.31%, and 6.17% for acetylcarnitine, proline, hydroxyproline, citrulline, and arginine, respectively. The developed assay was successfully applied to monitor the changes of the plasma levels of the five amino acids in rats and Beagle dogs following repeated oral administrations of aceclofenac. In rats, plasma concentrations of proline, hydroxyproline, and citrulline were significantly reduced after 4 days of aceclofenac administration compared to the control group. In dogs, plasma concentrations of proline and citrulline were significantly decreased after 7 days of aceclofenac administration compared to those obtained after the first aceclofenac administration. These data indicate that plasma levels of proline, hydroxyproline, and citrulline may be used as quantitative biomarkers of NSAIDs-induced gastric damage. The present assay could also be utilized to monitor the changes of these amino acids as potential indicators for various physiological and pathophysiological conditions.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Acetylcarnitine; Arginine; Citrulline; Hydroxyproline; LC–MS/MS; Proline

Mesh:

Substances:

Year:  2018        PMID: 30522064     DOI: 10.1016/j.jpba.2018.11.051

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Proteomic Analysis of MYB-Regulated Secretome Identifies Functional Pathways and Biomarkers: Potential Pathobiological and Clinical Implications.

Authors:  Haseeb Zubair; Girijesh Kumar Patel; Mohammad Aslam Khan; Shafquat Azim; Asif Zubair; Seema Singh; Sanjeev Kumar Srivastava; Ajay Pratap Singh
Journal:  J Proteome Res       Date:  2020-01-27       Impact factor: 4.466

2.  UPLC-Q-TOF/MS-Based Serum and Urine Metabonomics Study on the Ameliorative Effects of Palmatine on Helicobacter pylori-Induced Chronic Atrophic Gastritis.

Authors:  Xing Chen; Jianzhong Zhang; Ruilin Wang; Honghong Liu; Chunmei Bao; Shihua Wu; Jianxia Wen; Tao Yang; Ying Wei; Sichen Ren; Yuling Tong; Yanling Zhao
Journal:  Front Pharmacol       Date:  2020-09-15       Impact factor: 5.810

3.  Separation of 9-Fluorenylmethyloxycarbonyl Amino Acid Derivatives in Micellar Systems of High-Performance Thin-Layer Chromatography and Pressurized Planar Electrochromatography.

Authors:  Beata Polak; Adam Traczuk; Sylwia Misztal
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.